Diagnosis of HIV and syphilis HIV treatment and care Syphilis treatment and care Postnatal care Infant and child health The assessment includes central-level programmes and service delivery level, both primary- and care provided by public and private providers. It is recommended to align the service delivery sites selected for programme assessment with the sites selected for data verification. Informants to be included in the assessment should include the following: Central-level programme managers Provincial-level programme managers Service providers (public and private) in maternal and child health (MCH) Civil society representatives and women living with HIV and or syphilis. The checklist below should be used to assess the following: (1) assessment of central-level programme, (2) assessment of service delivery The tolls below should be used to conduct the following: (1) interviews with national and regional programme managers (2) interviews with service providers (3) interviews with civil society representatives, including women living with HIV and syphilis Please review the checklist and the content of the country report provided to you. Consider emphasizing any area that you think needs to be confirmed or for which you need additional information during the interviews. III. DATA ANALYSIS AND SUMMARIZATION The members of the validation team will be responsible for the programme assessment and will utilize the tools to complete the field visits and interviews. Data analysis will be summative, completing a checklist for each region visited (multiple sites), based on analysis of the team regarding each item on the checklist. The same process will be completed at the national level, utilizing the results of the regional analysis and checklists, to arrive at a national valuation of each item on the checklist. Based on the evaluation of individual items, a consensus conclusion will be reached by the validation team regarding the strengths, challenges, conclusions and recommendations for each of the components or building blocks in the tool. The validation team can consider the following questions in the analytical process:
Diagnosis of HIV and syphilis HIV treatment and care Syphilis treatment and care Postnatal care Infant and child health The assessment includes central-level programmes and service delivery level, both primary- and care provided by public and private providers. It is recommended to align the service delivery sites selected for programme assessment with the sites selected for data verification. Informants to be included in the assessment should include the following: Central-level programme managers Provincial-level programme managers Service providers (public and private) in maternal and child health (MCH) Civil society representatives and women living with HIV and or syphilis. The checklist below should be used to assess the following: (1) assessment of central-level programme, (2) assessment of service delivery The tolls below should be used to conduct the following: (1) interviews with national and regional programme managers (2) interviews with service providers (3) interviews with civil society representatives, including women living with HIV and syphilis Please review the checklist and the content of the country report provided to you. Consider emphasizing any area that you think needs to be confirmed or for which you need additional information during the interviews. III. DATA ANALYSIS AND SUMMARIZATION The members of the validation team will be responsible for the programme assessment and will utilize the tools to complete the field visits and interviews. Data analysis will be summative, completing a checklist for each region visited (multiple sites), based on analysis of the team regarding each item on the checklist. The same process will be completed at the national level, utilizing the results of the regional analysis and checklists, to arrive at a national valuation of each item on the checklist. Based on the evaluation of individual items, a consensus conclusion will be reached by the validation team regarding the strengths, challenges, conclusions and recommendations for each of the components or building blocks in the tool. The validation team can consider the following questions in the analytical process: